Survival rates for elderly patients receiving stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

September 27, 2016 — Carestream Health announced that it will be displaying a wide range of products at the 2016 Annual ...

Elekta announced that it has expanded its partnership with Radiating Hope, a volunteer organization that provides radiation equipment to resource-constrained countries. The organization also educates medical physics and radiation oncology personnel in those countries to help better serve their patient populations.

RaySearch and Mevion Medical Systems are extending their collaboration agreement to support the RayCare oncology information system (OIS), currently in development at RaySearch, and to take full advantage of the advanced treatment capabilities of the Mevion S250i with Hyperscan and Adaptive Aperture. The agreement was announced at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.

September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined ...

Stereotactic radiosurgery (SRS) for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates compared to observation alone following surgical resection. These conclusions were drawn from research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

New research suggests hypofractionated radiation therapy (RT) offers similar results to standard RT in several key areas for stage II and III non-small cell lung cancer (NSCLC) patients who are unable to receive standard treatments of surgery or chemoradiation (CRT). Hypofractionated RT showed similar results in overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times.

ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and conventional radiation therapy facilities in the United States, with plans to collaborate worldwide. The system is comprised of the Z-Box, Z-Square and Z-Tilt. The team from ZDi will be attending the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston Sept. 25-28 to demonstrate the technology.

Mevion Medical Systems announced that it will be installing its Mevion S250i proton therapy system at the Zuidoost Nederland Protonen Therapie Centrum, BV (ZON-PTC) in the Netherlands. The system delivers high-quality adaptive intensity modulated proton therapy (IMPT) with Mevion’s Hyperscan pencil beam scanning and Adaptive Aperture technology.

At the 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston, Siemens Healthineers will debuts new hardware and software offerings for imaging for radiation therapy (RT). The new Somatom Confidence RT Pro dedicated computed tomography (CT) scanner is designed to reduce unnecessary workflow steps and features technology that is intended to advance quality care while enabling personalized scans. The scanner features the new version of the company’s optional software syngo.via RT Image Suite, which is designed to help radiation oncology professionals increase efficiency with integrated image assessment, contouring and patient marking in one solution.